1
|
Cro S, Smith CH. Response to: 'Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)': reply from authors. Br J Dermatol 2021; 186:909-910. [PMID: 34878650 DOI: 10.1111/bjd.20944] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- S Cro
- Imperial Clinical Trials Unit, Imperial College London, London, W12 7RH, UK
| | - C H Smith
- St John's Institute of Dermatology, Guy's Hospital, NHS Foundation Trust, Guy's and St Thomas, London, SE1 9RT, UK
| |
Collapse
|